ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AZTR Azitra Inc

0.2239
-0.001 (-0.44%)
Apr 25 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 228,209
Bid Price
Ask Price
News -
Day High 0.229

Low
0.1605

52 Week Range

High
5.18

Day Low 0.21
Company Name Stock Ticker Symbol Market Type
Azitra Inc AZTR AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.001 -0.44% 0.2239 19:58:11
Open Price Low Price High Price Close Price Prev Close
0.2205 0.21 0.229 0.2201 0.2249
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
549 228,209 $ 0.2149182 $ 49,046 - 0.1605 - 5.18
Last Trade Time Type Quantity Stock Price Currency
20:00:00 100 $ 0.2201 USD

Azitra Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.66M 12.10M - 686k -12.64M -1.04 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Azitra News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AZTR Message Board. Create One! See More Posts on AZTR Message Board See More Message Board Posts

Historical AZTR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.2090.240.180.2128673952,6870.01497.13%
1 Month0.2050.260.16050.2067987786,2650.01899.22%
3 Months1.271.270.16050.2385821719,811-1.05-82.37%
6 Months1.492.280.16050.2927316349,015-1.27-84.97%
1 Year4.265.180.16050.4378436211,831-4.04-94.74%
3 Years4.265.180.16050.4378436211,831-4.04-94.74%
5 Years4.265.180.16050.4378436211,831-4.04-94.74%

Azitra Description

Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library comprised of approximately 1,500 bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its product ATR-12 is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its product ATR-04 is a genetically modified strain of S. epidermidis for treating the papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease.

Your Recent History

Delayed Upgrade Clock